NewAmsterdam Pharma Company NV Warrant

Quarterly Financials

Values in thousands 2024-12-31 2024-09-30 2024-06-30 2024-03-31
Revenue
$12,772
$29,111
$2,127
$1,298
Gross Profit
12,772
29,111
2,109
1,298
EBITDA
-111,693
-23,840
-49,061
-54,574
EBIT
-111,744
-23,868
-49,078
-54,587
Net Income
-92,177
-16,647
-36,413
-86,893
Net Change In Cash
12,772
29,111
2,127
1,298
Free Cash Flow
-37,484
-12,577
-50,492
-51,165
Cash
771,743
422,729
401,333
414,927
Basic Shares
94,358
94,754
94,711
82,160

Annual Financials

Values in thousands 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Revenue
$45,563
$12,762
$95,905
$0
Gross Profit
45,563
12,762
95,905
-14
EBITDA
-241,486
-176,861
-3,313
-30,726
EBIT
-176,289
-176,910
-3,321
-30,730
Net Income
-241,598
-176,937
-21,137
-36,712
Net Change In Cash
45,563
12,762
95,905
0
Free Cash Flow
-159,236
-141,242
7,959
-25,184
Cash
771,743
340,450
438,522
53,092
Basic Shares
94,358
82,161
18,966
17,751